IVF Surrogacy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Surrogacy is an arrangement in which a woman (the surrogate, or gestational carrier) carries and gives birth to a baby for another person or couple (the intended parents). IVF surrogacy — more precisely known as gestational surrogacy — is the most widely practised form, in which the embryo transferred to the surrogate is created in the IVF laboratory from the intended parents' own gametes (eggs and sperm), or from donor eggs and/or donor sperm. The surrogate has no genetic relationship to the baby she carries.

This distinguishes gestational surrogacy from traditional surrogacy, in which the surrogate's own egg is used — making her the genetic mother of the child. Traditional surrogacy is now practised rarely in regulated settings due to its significantly more complex legal and psychological landscape. The remainder of this guide focuses on gestational (IVF) surrogacy.

The IVF process in gestational surrogacy involves:

1. Ovarian stimulation and egg retrieval from the intended mother (or egg donor)
2. Fertilisation of the eggs with the intended father's sperm (or donor sperm) in the IVF laboratory
3. Culture of the resulting embryo(s) to blastocyst stage (Day 5–6)
4. Cryopreservation of the embryo(s) while the surrogate's uterus is prepared
5. Frozen embryo transfer (FET) into the surrogate's prepared uterine cavity
6. Luteal phase support and pregnancy confirmation

Surrogacy is primarily considered when the intended mother cannot carry a pregnancy due to congenital absence or surgical removal of the uterus (Rokitansky syndrome, post-hysterectomy), severe uterine abnormalities, medical conditions making pregnancy dangerous (severe cardiac disease, prior pelvic radiation), or repeated unexplained implantation failure despite good embryo quality. It is also the only route to biological parenthood for single men and male same-sex couples using their own sperm.

Important: Surrogacy law varies dramatically between countries. This page provides medical and general legal information only — not legal advice. Intended parents must consult a specialist family law solicitor in both their home country and the country of the surrogate before entering any surrogacy arrangement.

Gestational surrogacy is medically indicated when the intended mother cannot safely carry a pregnancy or has an absent uterus. Principal indications include:

Absent or Non-Functional Uterus

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome — congenital absence of the uterus and upper vagina — is present in approximately 1 in 5,000 women and is among the clearest medical indications for gestational surrogacy. The ovaries are structurally and functionally normal, meaning the intended mother can undergo ovarian stimulation and produce her own eggs for the IVF process.

Hysterectomy (surgical removal of the uterus) performed for cancer, severe haemorrhage, fibroids, or obstetric emergency also necessitates surrogacy for biological parenthood if the ovaries remain functional and the woman's own eggs are available or cryopreserved.

Severe Uterine Abnormalities

Significant Asherman's syndrome (intrauterine adhesions from prior surgery or infection), large intracavitary fibroids unamenable to surgery, severe uterine hypoplasia, or unicornuate uterus with repeated pregnancy losses may qualify as indications for surrogacy after failure of uterine surgery or repeated IVF failure attributable to uterine factors.

Medical Contraindications to Pregnancy

Conditions in which pregnancy poses a serious maternal health risk may justify surrogacy: WHO Class III–IV cardiac disease (including certain congenital heart defects, pulmonary hypertension), active malignancy or post-oncology treatment precluding pregnancy, severe systemic lupus erythematosus (SLE) with organ involvement, and prior radiotherapy to the pelvis damaging the uterus.

Recurrent Unexplained Implantation Failure

A small proportion of women with a structurally normal uterus experience repeated failure to achieve implantation after multiple high-quality blastocyst transfers. After thorough investigation (ERA endometrial receptivity testing, immune evaluation, thrombophilia screening) and optimisation of the endometrial environment, surrogacy may be considered when uterine receptivity is established as the limiting factor.

Single Men and Male Same-Sex Couples

For men who wish to have biological children, gestational surrogacy using donor eggs and the intended father(s)' sperm is the only available pathway. Legal access to surrogacy for this group varies widely by country.

Eligibility requirements for both intended parents and surrogates are determined by a combination of medical, psychological, and legal criteria.

Intended Parents

A medical indication or social reason for surrogacy must be established. The intended mother (or egg donor) must undergo a standard IVF assessment: ovarian reserve (AMH, AFC), uterine evaluation (to assess any residual uterine anatomy), and general health screening. Psychological assessment of both intended parents is required in all regulated surrogacy programmes — this assesses motivation, understanding of the arrangement, preparedness for potential complications (miscarriage, foetal anomaly, surrogate health problems), and the emotional complexity of surrogacy.

Surrogate Eligibility

Most accredited programmes and guidelines (ASRM, BFS/RCOG in the UK) recommend that surrogates:

• Are aged 21–45 (some programmes 21–40), with an upper age limit reflecting uterine and obstetric risk
• Have completed their own family (have had at least one prior uncomplicated pregnancy and delivery of their own children) — this ensures they have demonstrated uterine function and have experienced parenthood before carrying for someone else
• Have a body mass index (BMI) of 18–32 (some programmes 18–30) — obesity increases obstetric complication rates including gestational diabetes, hypertension, and caesarean section
• Are non-smokers and do not use recreational drugs or alcohol to excess
• Are free of sexually transmitted infections (HIV, hepatitis B and C, syphilis) at the time of screening
• Have a normal uterus on hysteroscopy or 3D ultrasound
• Pass a full psychological assessment confirming genuine altruistic motivation, a stable social support network, and understanding of the legal implications of surrendering parental rights
• Receive independent legal advice from a solicitor independent of the intended parents' legal team

The psychological screening of the surrogate is not merely a bureaucratic box-tick — it is a critical safeguard. It assesses the surrogate's understanding that the baby is genetically unrelated to her, her plans for managing the emotional experience of pregnancy and birth, her family's support, and her exit strategy if the arrangement becomes emotionally difficult.

IVF surrogacy is a multi-stage process involving coordinated medical treatment of both the intended mother (or egg donor) and the surrogate.

Stage 1: Legal Framework First

Before any medical treatment begins, the legal framework must be established. In the UK, for example, a surrogacy agreement is prepared — though it is not legally enforceable under the Surrogacy Arrangements Act 1985, it documents the parties' intentions and is referenced in subsequent court proceedings. In countries such as the USA (California, Nevada, Illinois, Washington) or Ukraine, a legally enforceable pre-birth order can be obtained, which recognises the intended parents as the legal parents from birth. Legal planning at this stage prevents the serious complications that arise when intended parents attempt to take a baby home across international borders without the appropriate parental legal status.

Stage 2: Embryo Creation (IVF)

The intended mother undergoes ovarian stimulation with FSH injections, monitored by serial ultrasound and hormone levels. Eggs are retrieved under sedation, fertilised with the intended father's (or donor) sperm, and cultured to blastocyst stage (Day 5–6). Blastocysts are biopsied for preimplantation genetic testing for aneuploidies (PGT-A) in many international programmes to maximise the chance of a euploid (chromosomally normal) embryo transfer. All embryos are cryopreserved (vitrified) while the surrogate's endometrium is prepared separately.

Stage 3: Surrogate Endometrial Preparation

The surrogate's own menstrual cycle is temporarily suppressed with a GnRH agonist (downregulation), and her endometrium is then built up using daily oestradiol (oral or patches), aiming for an endometrial thickness of ≥7–8 mm with a trilaminar pattern on ultrasound. Once optimal endometrial development is confirmed, progesterone pessaries or injections are added for 5–6 days to synchronise the endometrium with the developmental stage of the frozen blastocyst, after which embryo transfer is performed.

Stage 4: Embryo Transfer and Pregnancy Confirmation

One (or occasionally two) vitrified blastocyst(s) are thawed and transferred into the surrogate's uterine cavity under ultrasound guidance — an outpatient procedure taking approximately 10 minutes with no anaesthetic. Luteal phase support (progesterone, low-dose aspirin, sometimes clexane) continues. A serum beta-hCG test 14 days after transfer confirms pregnancy. A 6–7-week viability scan confirms foetal heartbeat and number.

Stage 5: Pregnancy and Birth

The surrogate attends standard antenatal care throughout the pregnancy. The intended parents are usually involved in antenatal appointments and birth planning. Birth plan documentation should specify the intended parents' presence at birth and immediate newborn care responsibilities, agreed in advance with the obstetric team.

Stage 6: Legal Parenthood After Birth

In the UK, the surrogate (and her husband or civil partner, if any) is the legal parent at birth regardless of genetic status. Intended parents must apply for a Parental Order in the Family Court within 6 months of the child's birth to permanently transfer parental rights. In countries with pre-birth orders (some US states, Ukraine), intended parents are named on the birth certificate from birth.

For those who qualify medically and legally, gestational surrogacy offers unique and profound advantages:

Biological Connection to the Child

Gestational surrogacy allows intended parents to have a child genetically related to one or both of them — the intended mother's eggs and/or the intended father's sperm are used. This is the defining characteristic that distinguishes surrogacy from adoption, and it is the primary reason many families choose this pathway.

Medical Optimisation of Embryo Quality

Because embryos are created in the IVF laboratory, they can be cultured to blastocyst stage, graded by Gardner/Schoolcraft criteria, and screened by PGT-A to select euploid (chromosomally normal) embryos. This optimisation is particularly valuable when the intended mother is older or has a history of recurrent miscarriage — the uterine environment of a healthy young surrogate dramatically improves implantation rates compared with a maternal uterus affected by age or disease.

Enabling Parenthood for Those Otherwise Unable

For women with uterine factor infertility, life-threatening medical contraindications to pregnancy, or who have been rendered infertile by cancer treatment, surrogacy is not merely a preference — it is the only route to biological parenthood. For single men and male same-sex couples, it is similarly the only biological pathway to fatherhood.

Surrogate Success Rates

Because the surrogate has been medically screened and has demonstrated previous uncomplicated pregnancy, implantation rates per embryo transfer in gestational surrogacy are often higher than in standard IVF cycles for the intended mother (who may have uterine or age-related factors affecting implantation). Published live birth rates per embryo transfer in surrogacy programmes using PGT-A-screened blastocysts exceed 50–60% in many accredited programmes.

Surrogacy carries a complex mix of medical, legal, and psychosocial risks that intended parents and surrogates must fully understand before proceeding.

Medical Risks to the Surrogate

The surrogate assumes all obstetric risks of pregnancy and childbirth, including gestational diabetes (4–8%), pregnancy-induced hypertension (5–10%), pre-eclampsia (2–5%), caesarean section (which may be planned or emergency), and in rare cases, maternal mortality (approximately 1 in 10,000 births in high-income countries). Comprehensive health insurance for the surrogate, covering all pregnancy-related complications and income protection, is a non-negotiable ethical requirement of any legitimate surrogacy arrangement.

Medical Risks to the Intended Mother or Egg Donor

Ovarian stimulation carries the standard IVF risks including ovarian hyperstimulation syndrome (OHSS), egg retrieval complications (bleeding, infection, anaesthetic risk), and the rare risk of ovarian torsion. OHSS risk can be minimised by using a GnRH antagonist protocol with agonist trigger in women with polycystic ovary syndrome or high ovarian reserve.

Legal Risks (International Surrogacy)

International surrogacy — where the surrogate resides in a different country from the intended parents — creates a complex legal situation. The child may be born stateless (holding neither the intended parents' citizenship nor the country of birth's citizenship) if legal parentage is not established before the family attempts to travel. Countries such as Germany, France, and Italy do not recognise surrogacy arrangements, and intended parents who are citizens of these countries may face significant legal challenges in registering their child's birth. Legal advice specific to both countries of domicile is essential before any international arrangement begins.

Psychological and Relationship Risks

Relationship breakdowns between intended parents and the surrogate, disagreements over prenatal decisions (termination in case of foetal anomaly, selective reduction in multiple pregnancy), and the emotional complexity of pregnancy bonding all represent real risks in surrogacy arrangements. Ongoing independent psychological support for all parties, mandated by good clinical practice, mitigates but does not eliminate these risks.

Financial Exploitation and Unregulated Agencies

Some jurisdictions with limited regulation attract surrogacy arrangements that exploit economically vulnerable women as surrogates. Intended parents should use only accredited agencies with transparent fee structures, verified surrogate screening, and independent legal representation for the surrogate.

The legal and practical steps after birth are as important as the medical steps before it. Failure to navigate these correctly can result in devastating consequences for the child and intended parents.

Parental Order (United Kingdom)

In the UK, a Parental Order application must be filed with the Family Court within 6 months of the child's birth. The court assesses whether: (1) the child is genetically related to at least one intended parent; (2) the surrogate has given her full and unconditional consent at least 6 weeks after birth; (3) no money beyond 'reasonable expenses' has been paid (though courts regularly retrospectively authorise higher payments); and (4) the arrangement is in the best interests of the child. Once granted, the Parental Order is permanent and the surrogate permanently relinquishes all parental rights. A new birth certificate naming the intended parents is issued.

Pre-Birth Orders (USA and Ukraine)

In US states with permissive surrogacy law (California, Nevada, Illinois, Maine, Washington, and others), intended parents can obtain a court pre-birth order during the third trimester of pregnancy, naming them as legal parents before the child is born. This means the birth certificate is issued directly in the intended parents' names at birth, without post-birth court proceedings. Ukraine issues a similar pre-birth document under Ukrainian law.

International Travel Documents

When a baby is born abroad through surrogacy, intended parents must obtain the appropriate travel documentation — which may require a DNA test to prove genetic relationship before a passport or emergency travel document is issued. This process can take weeks and has occasionally left families stranded abroad. Planning travel documents well in advance through the appropriate consular authority is essential.

Long-Term Psychological Support

Research published in the journal Human Reproduction indicates that children born through surrogacy have positive psychological outcomes when the arrangement is disclosed openly and age-appropriately. Intended parents should be supported in developing a narrative about surrogacy to share with their child as they grow. Both the surrogate's family and the intended parents' family may benefit from access to a counsellor experienced in donor-conception and surrogacy psychology.

Surrogacy is one of the most expensive routes to parenthood. Costs vary dramatically between countries depending on legal framework, surrogate compensation, medical fees, and agency charges.

United Kingdom (Altruistic Surrogacy Only)

Under UK law, commercial surrogacy is prohibited (Surrogacy Arrangements Act 1985). Surrogates may only receive 'reasonable expenses,' which courts have interpreted to include loss of earnings, maternity clothing, travel, and wellbeing costs — typically £12,000–£20,000. Legal fees (Parental Order application, surrogate's independent legal advice, clinic contracts) add £5,000–£15,000. IVF treatment costs at a UK clinic add £5,000–£8,000 per cycle. Total UK altruistic surrogacy costs: approximately £30,000–£60,000.

United States (Commercial Surrogacy, Full-Service)

The USA — particularly California — is the world's most established commercial surrogacy destination with the most comprehensive legal protections. Total costs typically range from $120,000–$200,000, including: surrogate base compensation ($40,000–$65,000), agency fee ($20,000–$35,000), legal fees ($15,000–$25,000), medical costs ($25,000–$40,000), insurance ($15,000–$25,000), and miscellaneous expenses.

Ukraine and Georgia (Commercial Surrogacy)

Ukraine and Georgia permit commercial heterosexual couple surrogacy (same-sex couples and singles are excluded by law in Ukraine). All-inclusive agency packages in Ukraine cost $40,000–$60,000. Costs are lower but legal and geopolitical risks (heightened since 2022 for Ukraine) must be weighed carefully.

Canada (Altruistic Surrogacy)

Canada permits altruistic surrogacy only. Surrogates may be reimbursed expenses up to CAD $30,000 under a 2018 regulatory framework. Medical costs at Canadian fertility clinics add CAD $20,000–$30,000. Legal fees add CAD $8,000–$15,000. Total: approximately CAD $60,000–$80,000.

India, Thailand, Cambodia

India, Thailand, and Cambodia have all progressively restricted or banned commercial surrogacy for foreign nationals since 2012–2016, following widely reported exploitation concerns. Intended parents should not pursue surrogacy in countries without a clear, stable legal framework as of the date of their arrangement.

Surrogacy is a complex, expensive, and legally demanding pathway. Before committing, intended parents should explore whether any alternatives apply to their situation.

Uterus Transplantation

Uterine transplantation (UTx) is an emerging experimental procedure in which a donor uterus (from a living related donor or deceased donor) is transplanted into a woman with uterine factor infertility. It has resulted in over 30 live births worldwide (as of 2025), predominantly from pioneering centres in Sweden, the USA, Czech Republic, and India. UTx remains confined to research protocols, requires immunosuppression during pregnancy, and the transplanted uterus is surgically removed after childbearing is complete. It is a genuine alternative to surrogacy for women with MRKH syndrome, but availability is extremely limited.

Adoption

Domestic or international adoption provides a route to parenthood without genetic connection to the child. Adoption processes are regulated differently in each country; international adoption has become significantly more complex and restricted since the Hague Convention on Intercountry Adoption came into force. Adoption does not involve fertility treatment and avoids the legal complexity of surrogacy, but typically involves extended waiting periods and means tests.

Foster to Adopt

Some countries (UK, USA) have pathways where prospective adoptive parents foster a child with the intention of adopting, providing a route to parenthood for a child who has entered the care system.

Child-Free Parenting (Living without Children)

For some couples who reach the end of fertility treatment, the decision to build a fulfilling life without children is a valid and increasingly recognised outcome supported by specialised counselling. Fertility counsellors trained in loss and life transition can provide significant support through this process.

The decision to pursue surrogacy should be made after exploring all alternatives, with full information about the legal landscape in the intended country, independent legal advice, and psychological support throughout the decision-making process.